ABSTRACT

Introduction Infantile/neonatal hemangioma and congenital vascular malformation are usually classified into a single vascular anomaly group. They are separate clinical entities where each behaves differently and has a very different clinical course. Because of this distinction, the diagnosis and management of each are entirely different.1 Infantile/neonatal hemangioma, in general, represents a “vascular tumor” with self-limiting growth,1,2

while congenital vascular malformation (CVM) represents a chronic, embryologically derived vascular lesion.3 Proper diagnosis is therefore essential for the appropriate management of both conditions.